Healthcare Investing News Market News Pfizer Announced FDA Approval of NYVEPRIA Author Bryan ShinPosted on 06/12/202006/12/2020 9147 Pfizer Inc. (NYSE: PFE) announced Thursday that the United States (U.S.) Food and Drug Administration (FDA) has approved NYVEPRIA™ (pegfilgrastim-apgf), a biosimilar to Neulasta® (pegfilgrastim). NYVEPRIA is indicated to...